Scroll To Top
Search by Speciality

35TH ANNUAL CFS: INNOVATIVE CANCER THERAPY FOR TOMORROW®

New York Marriott Marquis Hotel * | New york city, USA
From 249 to 849 USD
Event Preview
19
Days Left
For the
Event
Title: 35TH ANNUAL CFS: INNOVATIVE CANCER THERAPY FOR TOMORROW®
Specialty: Hematology and Hemotherapy
Dates: From Nov, 8, 2017 to Nov, 10, 2017
Location: New york city, USA
Type: Symposium
Registration Cost: From 249 to 849 USD
Event Tools
  • Add to Favorites
  • Notify me by email
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Nov
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for New York City, Usa.
General Info
Event Venue:

New York Marriott Marquis Hotel *

New York City, USA Visit the Venue to read more
Currency:
USD
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Advances in all aspects of cancer care—including diagnostic, therapeutic, and supportive strategies—form the foundation for recent changes in the management of solid and hematologic malignancies. For many tumor types, integration into practice of novel testing approaches, systemic therapies, molecular targeted therapies, immunotherapies, and multimodal strategies, continue to improve patient outcomes in multiple lines of care. Each year, the CFS®, brings together more than 2,000 oncologists, hematologists, radiation oncologists, immunologists, pharmacists, oncology nurses, nurse practitioners, physician assistants, and case managers, with the aim of promoting the delivery of state-of-the-art cancer care for the most challenging clinical scenarios. At the 34th Annual CFS®, our internationally renowned faculty will provide expert insights on the latest developments in cancer therapeutics. This exciting 3-day program will offer oncology practitioners an unparalleled opportunity to learn how innovative approaches fit into evolving treatment paradigms to optimize care and outcomes for their patients with cancer.


Target Audience


This educational activity is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists interested in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other healthcare professionals interested in the treatment of cancer are also invited to attend.


2017 Hot Topics


Immunotherapies and Their Latest Applications in Cancer, Including Combinations

Harnessing the Latest Technologies, Biomarkers, and Tests to Optimize Clinical Decision Making

Microsatellite Instability‒Guided Care Across Multiple Tumor Types

How to Maximize Outcomes in Multiple Myeloma

Factoring MRD Into Treatment Plans for Patients With Hematologic Malignancies

Tackling Clinical Challenges in the Management of Myeloproliferative Neoplasms

Practice-Changing Paradigms in Acute Leukemias

Providing State-of-the-Art Care for Older Patients With Hematologic Malignancies

Coming Soon to Your Clinic: Evolving Strategies for Hepatocellular Carcinoma, Pancreatic Cancer, and Gastric Cancer

Options and Considerations for Metastatic Colorectal Cancer in the Frontline and Beyond Progression

Progress in Soft-Tissue Sarcoma and Non‒Soft-Tissue Sarcoma

Ovarian Cancer: PARP Inhibition, Maintenance Strategies, Immunotherapy, Angiogenesis Targeting, and Clinical Trial Designs

Novel Therapeutic Approaches in Breast Cancer Treatment: Immunotherapy and Combinations

Treatment Planning for Early, HER2-Positive Breast Cancer: Neoadjuvant and Adjuvant Considerations

Individualized Care for Patients With Advanced Triple-Negative Breast Cancer

Precision Care for Patients With Non-Small Cell and Small Cell Lung Cancer

Bladder Cancer: More Options, More Clinical Considerations

New Horizons in Prostate Cancer: Expert Sequencing, Targeting DNA Repair Deficiency, and Immunotherapy

Updates in Glioblastoma: Technologies, Targeted Therapy, and Immunotherapy

Optimizing Your Patients’ Quality of Life: Focus on CINV, Sexuality, and Palliation

Advances in Melanoma and Nonmelanoma Carcinomas

Cancer-Associated Cardiomyopathy: Web-Based Diagnostic and Management Technologies

Moon Shots Program™ Update

Speakers/Faculty:

Ajai Chari, MD

Associate Professor

Medicine, Hematology and Medical Oncology

The Mount Sinai Hospital

New York, NY

 

Maura N. Dickler, MD

Interim Chief, Breast Medicine Service

Section Head, Endocrine Therapy Clinical Research Program

Associate Member, Memorial Sloan Kettering Cancer Center

Division of Solid Tumor Oncology

Department of Medicine

Associate Professor of Medicine, Weill Cornell Medical College

New York, NY

 

Alexander Drilon, MD

Clinical Director, Early Drug Development Service

Assistant Attending Physician, Thoracic Oncology Service

Memorial Sloan Kettering Cancer Center

New York, NY

 

Cathy Eng, MD, FACP

Professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine

Director, Department of Gastrointestinal Medical Oncology, Network Clinical Research

Associate Medical Director, Colorectal Center, Division of Cancer Medicine

The University of Texas MD Anderson Cancer Center

Houston, TX

 

Jason Luke, MD, FACP

Assistant Professor of Medicine

The University of Chicago Medicine

Chicago, IL


Co-Chair Emeritus

Edward Ambinder, MD

Clinical Professor

Medicine, Hematology and Medical Oncology Clinical

Professor, Oncological Sciences

Mount Sinai Hospital

New York, NY

 

Franco Muggia, MD

Professor, Department of Medicine

NYU Langone Medical Center

New York, NY

Registration Needs updating Register Now
Currency:

USD

Registration Cost
Type
Early Registration

2017-08-11
Late Registration From: 2017-08-12 To: 0--
On site Registration
Physician
599
699
0
Fellows
249
349
0
Nurses , PAs
249
349
0
Industry
749
849
0

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

New York Marriott Marquis

1535 Broadway

New York, NY 10036

888-523-0366

 

A limited block of rooms has been set aside at the New York Marriott Marquis at a run-of-house rate of $397 (single/double) plus applicable state and local taxes. Rates and rooms are subject to availability at the time of the reservation.



To make a reservation, call (800) 843-4898. The deadline for making your hotel reservations is October 16, 2017. After that date, or in the event that the room block becomes full prior to the deadline, rooms are subject to availability, and the room rates may increase. When booking, please mention the CFS™ to receive the discounted group rate. All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card.

 

All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. The hotel will not hold any reservations unless secured by one of the above methods.

Physicians’ Education Resource® (PER®) recommends that you make your airline reservations early to get the best seat options and lowest airfare available. The gateways to the NYC area are LaGuardia Airport (LGA, 9.5 miles) and John F. Kennedy International Airport (JFK, 18.5 miles) in NY, and Newark Liberty International Airport located in NJ (EWR, 16.5 miles).


You are invited to make your travel arrangements through PER’s travel partner, Singer Travel, at (610) 378-1610 between 9:00 am and 5:30 pm Eastern Standard Time. Please ask for Jill Schuler.


Accommodation Options and Cost

Hotel Name
Type of charge
Single
Room
Double
Room
Distance from Venue
New York Marriott Marquis
Date range
397
Scientific Content Up to Date
Submission Info

All poster abstract submissions must be made electronically through the PER® online abstract submission system.


The abstract should be a short description of your work and should contain all the elements necessary to define your goals and results to the reader, and include the components of the abstract body listed below. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. However, the formal poster session is not designated for credit. 


Share your research or best practices with your peers. Categories of submission include:


Hematologic Malignancies Gastrointestinal Cancers

Gynecologic Malignancies

Head and Neck Cancers

Oncology Informatics

Central Nervous System Tumors, Neuroendocrine Tumors

Breast Cancers

Soft Tissue Sarcoma

Lung Cancers

Melanoma and other Cutaneous Malignancies

Genitourinary Malignancies

Immunotherapies

Targeted Therapies, Regional Therapies, Chemotherapies

Personalized and Precision Medicine

Biomarkers, Testing, Sequencing

Survivorship, Patient Care Management, Team-Based Care

Clinical Trials

Healthcare Reform, Value-Based Care, Clinical Pathways

Other

The Program Chairs and Steering Committee will evaluate the scientific quality of the submitted abstracts based on the following criteria: novelty of the research, significance of the findings, and clarity. Incomplete abstracts will not be reviewed.


Notification of acceptance or regret will be delivered via e-mail to the presenters of each poster abstract by mid-September. Please note that an author is required to be present during the poster session.


If accepted for presentation, abstracts and posters will be available for viewing online on the 2017 Chemotherapy Foundation Symposium website during and after the conference. A formal poster viewing will be held during the conference in the Exhibit Hall, where breakfast and refreshment breaks will also be held. The presentation at the conference should reflect the submitted abstract; abstract title, authorship, and content of the presentation must match the submitted abstract.


All presenters must register to attend the 35th Annual Chemotherapy Foundation Symposium. Please visit www.gotoper.com to register.

 


Submission Process


Complete the abstract template provided on the 2017 Chemotherapy Foundation Symposium website.

Limit is 2500 characters (abstract body, including spaces and table). 

Upload full abstract or poster where prompted.

Components of the abstract body – Limit: 2500 characters (1 table allowed)


Background/Significance — What was the problem and why was it important? What knowledge are you building on? What was the intent or goal of the study? What did you want to learn?

Materials and Methods — What was the trial design? What was the sample? What instruments were used? How were data collected and analyzed?

Results — What were the findings?

Conclusions — What do the findings mean?

FAQ


TIP abstracts are accepted.

Encore abstracts are accepted.

Abstract Questions


Please submit any questions pertaining to abstract submissions to abstracts@gotoper.com using the subject line “CFS Abstract QUESTION.”


Author Consent and Waiver of Claims


Each Abstract Author agrees and certifies that he or she:

Waives any and all claims against Physicians’ Education Resource®, LLC, sponsor of the 35th Annual Chemotherapy Foundation Symposium, and any reviewer arising out of or relating to the abstract submission and review process, including but not limited to peer review and the grading of abstracts.

Note: The hotel may sell out, and may to do so before the discounted cutoff date of October 16, 2017. Reservations should be made early!

Abstract submission deadline 2017-08-15
Sponsors Exhibitors
General Info

 Physicians' Education Resource, LLC

Phone: 609-378-3701

Fax: 609-257-0705

Email: info@gotoper.com

Contact
Organising Agency

 Physicians' Education Resource, LLC

Phone: 609-378-3701

Fax: 609-257-0705

Email: info@gotoper.com

Event map
Revelant Events